These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 28504662)

  • 1. Association between pretransplant iron overload determined by bone marrow pathological analysis and bacterial infection.
    Ohmoto A; Fuji S; Miyagi-Maeshima A; Kim SW; Tajima K; Tanaka T; Okinaka K; Kurosawa S; Inamoto Y; Taniguchi H; Fukuda T
    Bone Marrow Transplant; 2017 Aug; 52(8):1201-1203. PubMed ID: 28504662
    [No Abstract]   [Full Text] [Related]  

  • 2. Elevated pretransplant ferritin is associated with a lower incidence of chronic graft-versus-host disease and inferior survival after myeloablative allogeneic haematopoietic stem cell transplantation.
    Mahindra A; Bolwell B; Sobecks R; Rybicki L; Pohlman B; Dean R; Andresen S; Sweetenham J; Kalaycio M; Copelan E
    Br J Haematol; 2009 Aug; 146(3):310-6. PubMed ID: 19508292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and microbiological impact of long-term discontinuation of fluoroquinolone prophylaxis in haematological patients with prolonged profound neutropenia.
    Verlinden A; Schroyens WA; Gadisseur AP
    Eur J Haematol; 2021 Sep; 107(3):377-379. PubMed ID: 34018235
    [No Abstract]   [Full Text] [Related]  

  • 4. [The role of stromal and hematopoietic tissue interaction in pathology of hematopoiesis].
    Morozova VT
    Klin Lab Diagn; 2003 Aug; (8):33-6. PubMed ID: 14524126
    [No Abstract]   [Full Text] [Related]  

  • 5. Iron overload in myelodysplastic syndromes: Evidence based guidelines from the Canadian consortium on MDS.
    Leitch HA; Buckstein R; Zhu N; Nevill TJ; Yee KWL; Leber B; Keating MM; St Hilaire E; Kumar R; Delage R; Geddes M; Storring JM; Shamy A; Elemary M; Wells RA
    Leuk Res; 2018 Nov; 74():21-41. PubMed ID: 30286330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting the presence or absence of ringed sideroblasts in patients suspected of having a myelodysplastic syndrome and increased iron stores: a simple observation.
    Dorion RP; Alomari M; Wood GC
    Leukemia; 2001 Nov; 15(11):1793-5. PubMed ID: 11681424
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased Bone Marrow Iron Scores Are Strongly Correlated With Elevated Serum Ferritin Levels and Poorer Survival in Patients With Iron Overload That Underwent Allogeneic Hematopoietic Stem Cell Transplantation: A Single Center Experience.
    Sivgin S; Nazlim S; Zararsiz G; Baspinar O; Kaynar L; Deniz K; Cetin M; Unal A; Eser B
    Clin Lymphoma Myeloma Leuk; 2016 Oct; 16(10):582-587. PubMed ID: 27769559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eosinophilia indicates the evolution to acute graft-versus-host disease.
    Basara N; Kiehl MG; Fauser AA
    Blood; 2002 Oct; 100(8):3055. PubMed ID: 12382649
    [No Abstract]   [Full Text] [Related]  

  • 9. Iron overload in myelodysplastic syndromes.
    Chodirker L; Wells RA
    Expert Rev Hematol; 2009 Jun; 2(3):215-8. PubMed ID: 21082962
    [No Abstract]   [Full Text] [Related]  

  • 10. The evaluation of iron overload through hepcidin level and its related factors in myelodysplastic syndromes.
    Gu S; Song X; Zhao Y; Guo J; Fei C; Xu F; Wu L; Zhang X; Zhao J; Chang C; Li X
    Hematology; 2013 Sep; 18(5):286-94. PubMed ID: 23540794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of pre-transplant serum ferritin on outcomes of patients with myelodysplastic syndromes or secondary acute myeloid leukaemia receiving reduced intensity conditioning allogeneic haematopoietic stem cell transplantation.
    Lim ZY; Fiaccadori V; Gandhi S; Hayden J; Kenyon M; Ireland R; Marsh J; Ho AY; Mufti GJ; Pagliuca A
    Leuk Res; 2010 Jun; 34(6):723-7. PubMed ID: 19944463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum ferritin and disease status at transplantation predict the outcome of allo-SCT in patients with AML or myelodysplastic syndrome.
    Tachibana T; Takasaki H; Tanaka M; Maruta A; Hyo R; Ishigatsubo Y; Kanamori H
    Bone Marrow Transplant; 2011 Jan; 46(1):150-1. PubMed ID: 20383206
    [No Abstract]   [Full Text] [Related]  

  • 13. Pretransplant chest computed tomography screening in asymptomatic patients with leukemia and myelodysplastic syndrome.
    El Boghdadly Z; Oran B; Jiang Y; Rondon G; Champlin R; Kontoyiannis DP
    Bone Marrow Transplant; 2017 Mar; 52(3):476-479. PubMed ID: 27941772
    [No Abstract]   [Full Text] [Related]  

  • 14. How to manage iron toxicity in post-allogeneic hematopoietic stem cell transplantation?
    Kontoghiorghes GJ
    Expert Rev Hematol; 2020 Apr; 13(4):299-302. PubMed ID: 32037922
    [No Abstract]   [Full Text] [Related]  

  • 15. Ringed sideroblasts in primary myelodysplasia. Leukemic propensity and prognostic factors.
    Vandermolen L; Rice L; Rose MA; Lynch EC
    Arch Intern Med; 1988 Mar; 148(3):653-6. PubMed ID: 3341866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretransplant hyperferritinemia has no effect on the outcome of myeloablative cord blood transplantation for acute leukemia and myelodysplastic syndrome.
    Konuma T; Kato S; Oiwa-Monna M; Tojo A; Takahashi S
    Ann Hematol; 2014 Jun; 93(6):1071-2. PubMed ID: 24141336
    [No Abstract]   [Full Text] [Related]  

  • 17. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
    Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of HLA mismatch direction on the outcome of unrelated bone marrow transplantation: a retrospective analysis from the Japan Society for Hematopoietic Cell Transplantation.
    Kanda J; Ichinohe T; Fuji S; Maeda Y; Ohashi K; Fukuda T; Miyamura K; Iwato K; Eto T; Nakamae H; Kobayashi N; Mori T; Mori S; Morishima Y; Atsuta Y; Kanda Y;
    Biol Blood Marrow Transplant; 2015 Feb; 21(2):305-11. PubMed ID: 25464119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biology of the bone marrow microenvironment and myelodysplastic syndromes.
    Rankin EB; Narla A; Park JK; Lin S; Sakamoto KM
    Mol Genet Metab; 2015; 116(1-2):24-8. PubMed ID: 26210353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evolution of acute leukemia in myelodysplastic syndromes: prognostic histopathological factors in a series of bone marrow biopsies].
    Navone R; Ranco V; Pich A
    Pathologica; 1991; 83(1083):55-63. PubMed ID: 1866200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.